Rapid advancements in materials science and nanotechnology, intertwined with oncology, have positioned photothermal therapy (PTT) as a promising noninvasive treatment strategy for cancer. The breast's superficial anatomical location and aesthetic significance render breast cancer a particularly pertinent candidate for the clinical application of PTT following melanoma. This review comprehensively explores the research conducted on the various types of nanoparticles employed in PTT for breast cancer and elaborates on their specific roles and mechanisms of action. The integration of PTT with existing clinical therapies for breast cancer has been scrutinized, underscoring its potential for synergistic outcomes. Additionally, the mechanisms underlying PTT and consequential modifications to the tumor microenvironment after treatment are elaborated from a medical perspective. Future research directions are suggested, with an emphasis on the development of integrative platforms that combine multiple therapeutic approaches and the optimization of nanoparticle synthesis for enhanced treatment efficacy. The goal was to push the boundaries of PTT towards a comprehensive, clinically applicable treatment for breast cancer.Abstract Schema: PTT is integrated into four key aspects of breast cancer treatment: (A) Categorization of nanoparticles functioning as thermal cores used in photothermal agents for breast cancer treatment. (B) Depiction of ligands or targeted components employed for surface modification of nanoparticles. (C) The tripartite benefits of photothermal therapy in the management of breast cancer. (D) An overview of various clinical treatment strategies for breast cancer, with surgery at the core, accompanied by diverse adjuvant therapiesThis article is protected by copyright. All rights reserved